FDA rejects Rexulti's approval for PTSD treatment, citing insufficient evidence of effectiveness in combination with sertraline. Otsuka and Lundbeck announced they are planning next steps.
The Scottish government’s use of data is helping it assess the progress of infrastructure priorities that contribute to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback